ANEMIA IN PREGNANCY : MCQS AND IMPORTANT MCQS By DR MARIA RAFI

Image
  1.  A 30-year-old pregnant female is undergoing routine blood tests . Pregnancy is associated with an increase in which of the following? A) Mean Cell Hemoglobin Concentration (MCHC) B) Serum ferritin concentration C) Hematocrit D) Total Iron Binding Capacity (TIBC) ✅ Answer: D) Total Iron Binding Capacity (TIBC) Explanation: Pregnancy leads to increased TIBC due to higher transferrin synthesis to compensate for increased iron demand. Serum ferritin and iron decrease due to increased iron utilization. Hematocrit reduces due to physiological hemodilution , not an actual decrease in RBC mass. DR MARIA RAFI ;923324747587 2.  A 28-year-old female, para 2+0 , presents with Hb 7 g/dL . What is the next best investigation? A) Hb electrophoresis   B) Total iron-binding capacity (TIBC) C) MCV and peripheral smear ✅ D) Serum iron Answer: A) Hb electrophoresis Explanation: The first step is to check MCV (Mean Corpuscular Volume) to classify anemia...

Acute coronary syndromes in pregnancy: a literature review ; 15JUNE 2022 SUMMARY BY DR MARIA RAFI

Acute Coronary Syndromes (ACS) in Pregnancy

Introduction

  • 🌟 Rare but critical: ACS in pregnancy is a rare cause of maternal mortality.
  • đŸŠē Key to survival: Early recognition and a multidisciplinary team (MDT) approach improve outcomes.

Epidemiology and Risk Factors

  • 📊 Incidence:

    • 0.6–10 per 100,000 pregnancies worldwide.
    • Mortality rate: 5.1–11%.
    • UK MBRRACE-UK (2017–2019): Cardiovascular disease = leading cause of maternal deaths (17%).
  • 📈 Increased risk:

    • Pregnant women are 3–4 times more likely to suffer ACS than nonpregnant women.
    • Rising incidence due to increased maternal age and comorbidities.
  • 🔍 Risk Factors by Pathophysiology:

    • Pregnancy-Associated Spontaneous Coronary Artery Dissection (PASCAD):
      • Marfan syndrome, hypertension, family history of SCAD.
    • Atheromatous Disease:
      • Advanced age, obesity, smoking, diabetes, hypertension, dyslipidemia.
    • Thrombotic Risk:
      • Thrombophilia, hypertensive disorders, infections, multiparity, sickle cell disease.
      • Ergometrine use (linked to spasm).

Pathophysiology

  • 🔄 Physiological changes in pregnancy:
    • 50% increase in blood volume and cardiac output.
    • Increased basal heart rate; fluctuations in blood pressure and vascular resistance.
    • Prothrombotic state increases risk throughout pregnancy and postpartum.
  • 💔 Coronary Flow & Ischemia:
    • Even minor reductions in coronary flow can cause ischemia due to increased cardiac demand.

Types of ACS

1️⃣ ST-Elevation Myocardial Infarction (STEMI):

  • 🚨 Key Features:
    • ST elevation/new LBBB on ECG + symptoms (chest pain, SOB, arrhythmias).
    • Biomarkers raised, but ECG is diagnostic.
    • 🌟 Time-critical: Target: restore coronary flow within 1 hour.
  • đŸŠē Accounts for ~75% of maternal ACS presentations.

2️⃣ Non-ST Elevation MI (NSTEMI):

  • ⚠️ Clinical Presentation:
    • May include ST depression/T-wave inversion or normal ECG.
    • Raised biomarkers.
  • 🛠️ Requires individual risk assessment for emergency or conservative management.

3️⃣ Unstable Angina (UA):

  • đŸ’ĸ Symptoms: Chest pain or SOB at rest.
  • ECG may resemble NSTEMI but no biomarker rise.

4️⃣ Stable Angina:

  • ⏸️ Relieved by rest, no biomarker rise, and often normal ECG.

Aetiology of ACS in Pregnancy

  • 🩸 PASCAD (Pregnancy-Associated SCAD):

    • Found in ~27% of cases; up to 43% in older studies.
    • Common in late third trimester/early postpartum.
    • Intimal tear → false lumen → intramural hematoma → luminal collapse.
  • 🩹 Atherosclerosis:

    • Primary cause now due to maternal age and comorbidities.
    • Plaque rupture → thrombosis → coronary flow obstruction.
    • Seen in ~39–40% of cases.
  • 🔗 Thrombosis/Thromboembolism:

    • Found in 10–20% of cases.
  • đŸ’ĸ Coronary Artery Spasm:

    • Rare (~2% of cases)

    Clinical Presentation

    • 🌟 Typical Symptoms:

      • Chest or epigastric pain radiating to the neck or arm.
      • Shortness of breath (SOB).
    • 🔀 Atypical Symptoms (more common in women):

      • Nonspecific pain, nausea, vomiting, and back pain.
      • Dyspnoea, hyperhidrosis, and agitation.
    • ⚠️ Critical Notes:

      • Symptoms often downplayed or dismissed in pregnant women (cognitive diagnostic bias).
      • Examination may be unremarkable.
      • Vital signs may show haemodynamic instability.
    • đŸŠē ACS Subgroups Presentation:

      • PASCAD, Thrombosis, Coronary Artery Spasm: Typically present as STEMI or NSTEMI.
      • Atheromatous Disease: Can present as stable or unstable angina.
    • 🚨 Rare Presentation:

      • Cardiac arrest – managed per maternal cardiac arrest guidelines.
      • Always consider cardiac causes in cardiac arrest cases.
    • 🛠️ Differential Diagnosis:

      • Pulmonary embolism (PE).
      • Aortic dissection.
      • Pneumonia, gastro-oesophageal reflux disease, musculoskeletal pain, anxiety.

    Investigations

    Investigations for Myocardial Infarction (MI) đŸĨ💓

    • Electrocardiography (ECG) 📉

      • đŸŠē First-line test for diagnosing MI in patients with chest pain.
      • ST elevation is the most specific marker.
      • 📈 Serial ECGs are important as initial ECGs can be normal.
      • 🔍 Sensitivity of 12-lead ECG is ~50%, so other tests are needed.
    • Blood Cardiac Markers 🩸

      • Troponin I & Troponin T – Best markers for MI.
      • ⏳ Can take up to 12 hours to peak, so repeated testing is needed.
      • đŸšĢ Not affected by pregnancy, labor, or C-section.
      • ⚠️ Raised in pre-eclampsia & hypertension but stays below MI levels.
    • Echocardiogram (Heart Ultrasound) đŸĻģđŸĢ€

      • 🔍 Helps rule out other conditions like aortic dissection.
      • 📊 Can assess heart function & wall motion abnormalities.
      • 🤰 Safe to use in pregnancy.
    • Coronary Angiography đŸĨ📡

      • 🛑 Gold standard for diagnosing & treating MI.
      • đŸŠģ Uses X-ray and contrast dye to check for blocked arteries.
      • 🤰 Safe in pregnancy if done with abdomen shielding & minimal radiation exposure.

    Management of ACS in Pregnancy

    General Principles

    • đŸŠē Multidisciplinary Team (MDT):
      • Involves obstetricians, cardiologists, anaesthetists, paediatricians, and the patient herself.
      • Care should be provided in facilities equipped with cardiac and obstetric intensive care units.
    • 🌟 Goal:
      • Stabilize the patient and individualize care based on clinical presentation and gestational age.

    Reperfusion Therapy for STEMI in Pregnancy

    • Primary Percutaneous Coronary Intervention (PPCI) 🚑💉

      • Gold standard treatment for STEMI.
      • Coronary angiography & stenting help restore blood flow.
      • Bare metal stents (BMS) are preferred over drug-eluting stents due to limited safety data.
      • Growing evidence supports successful PPCI outcomes in pregnancy.
    • Thrombolysis (Clot-Dissolving Therapy) 💊🩸

      • Used when PPCI is not immediately available.
      • Intravenous t-PA (tissue plasminogen activator) is the preferred thrombolytic agent.
      • Safe in pregnancy as it does not cross the placenta.
      • Review of 28 case reports found no risk of birth defects (teratogenesis).
    • Risks & Considerations ⚠️

      • Maternal bleeding risk (8%), which can lead to fetal distress.
      • Decisions should be made in consultation with a cardiologist.
      • Early intervention is crucial to improve outcomes for both mother and baby.

    Management of Non-ST Elevation Myocardial Infarction (NSTEMI) in Pregnancy

    🩸 First-Line Treatment: Antiplatelet Therapy

    • Goal: Prevent further clot formation, dissolve existing clots, and improve blood flow to the heart.
    • Medications Used:
      • Aspirin (Low-Dose) – Safe in pregnancy; reduces clot formation.
      • Clopidogrel (If Needed) – Used in selected cases but for the shortest duration possible.

    đŸĨ Coronary Angiography & Stenting

    • Indicated If:
      • Symptoms persist despite medical treatment.
      • Hemodynamic instability (low blood pressure, shock, etc.).
      • High-risk patients even after symptoms improve.
    • Procedure:
      • Angiography assesses the blockage.
      • Stenting (Revascularization) is done if required.
      • Discussed in multidisciplinary team meetings to balance risks and benefits.

    Medications Used in Acute Myocardial Infarction (AMI) in Pregnancy

    for prevention and treatment                                                                                                           đŸŠ¸ Antiplatelet & Anticoagulant Therapy

    • Aspirin (Low-Dose 60–150 mg) ✅

      • First-line medication for preventing further clot formation.
      • Safe in pregnancy (confirmed by the CLASP study).
      • Slight increase in blood transfusion post-delivery, but no significant risks to the mother or baby.
      • Avoid high-dose aspirin due to potential risks.
    • Clopidogrel (Thienopyridine Derivative) 🛑⚠️

      • Used after stenting if needed.
      • Limited safety data, so use for the shortest duration possible.
      • A case study reported no adverse effects with 75 mg for 2 weeks after stenting in pregnancy.
    • Heparin (Low-Molecular-Weight & Unfractionated) ✅

      • Safe in pregnancy as it does not cross the placenta.
      • Used to prevent further clot formation.
      • Must be stopped 24 hours before labor to avoid excessive bleeding.

    đŸĢ€ Blood Pressure & Vasodilator Medications

    • Labetalol (Beta-Blocker) ✅

      • Preferred beta-blocker for pregnancy.
      • Safe for controlling blood pressure and reducing heart strain.
    • Nitrates (e.g., Nitroglycerin) ✅⚠️

      • Used to widen blood vessels and improve blood flow.
      • Can be used in severe hypertension, pulmonary edema, and AMI.
      • Caution: Reports of fetal distress (bradycardia, loss of variability) with IV nitroglycerin.
    • Nifedipine (Calcium Channel Blocker) ⚠️

      • Safe in pregnancy, but should be avoided after an acute coronary event due to increased mortality risk.

    đŸšĢ Medications Contraindicated in Pregnancy

    • ACE Inhibitors & ARBs (e.g., Enalapril, Losartan) ❌

      • Severe fetal risks, including kidney damage, lung underdevelopment, growth restriction, and fetal death in the second & third trimester.
      • First-trimester use can cause heart and brain defects.
    • Statins (e.g., Atorvastatin, Rosuvastatin) ❌

      • Not recommended due to lack of safety data.

    ⏳ Timing of Delivery

    • Delay delivery by 2–3 weeks post-AMI if possible to reduce maternal mortality risk.
    • If preterm delivery is expected, administer maternal steroid injections early for fetal lung maturity.
    • Delivery must take place in high-risk obstetric units with intensive care facilities.

    🤰 Mode of Delivery: Vaginal vs. Cesarean Section

    • No clear preference—both vaginal and elective C-section are acceptable, depending on maternal & obstetric factors.

    • Vaginal Delivery Advantages
      ✔️ Less blood loss, infection, and thromboembolism risk
      ✔️ Epidural analgesia recommended to reduce stress on the heart & prevent excessive pushing.
      ✔️ Labour in the left lateral position to avoid pressure on major vessels.
      ✔️ Instrumental delivery (forceps/vacuum) advised to shorten the second stage and reduce heart strain.

    • Elective C-Section Advantages
      ✔️ Avoids labor-related hemodynamic stress (pain-induced BP spikes, pushing effort).
      ✔️ Allows planned delivery with a full medical team available.


    ⚠️ Key Considerations During Delivery

    • Continuous Monitoring: Maternal ECG, pulse oximetry, BP, and fetal heart rate.
    • Invasive Monitoring: Arterial catheter if left ventricular function is impaired.
    • Oxytocin (Slow IV Infusion <2U/min) to reduce postpartum hemorrhage risk without causing hypotension.
    • Avoid Ergometrine đŸšĢ due to its vasoconstrictive effect, which can trigger coronary artery spasm.

    🛌 Post-Delivery Care & Follow-Up

    • High-dependency/ICU monitoring for 24–48 hours post-delivery due to fluid shifts & cardiovascular instability.
    • Thromboembolic risk assessment & appropriate anticoagulation measures.
    • AMI Management During Delivery:
      • Beta-blockers, nitrates, and calcium channel blockers can be used if needed.
      • Nitroglycerin & calcium channel blockers may prolong labor due to tocolytic effects.
    • Postnatal Follow-Up:
      • General practitioner & cardiologist must be updated.
      • Contraception counseling based on cardiac function & AMI cause.
      • Future pregnancy recommendations depend on maternal heart recovery.

    5. Future Pregnancies

    • đŸŠē Preconception Counseling:
      • Essential for women with IHD or previous ACS.
      • Optimize cardiac function and switch teratogenic drugs to safer alternatives.
      • Delay pregnancy for at least 12 months post-acute coronary event.
    • 🛡️ Contraception:
      • Contraindicated methods: Estrogen-based contraceptives in IHD.
      • Preferred: Progestin-only or non-hormonal methods.

    Monitoring & Follow-Up

    • 🔍 Regular Monitoring:
      • MDT involvement throughout pregnancy.
      • Rapid assessment for any symptom changes.
    • 📋 Risk Stratification:
      • Use modified WHO classification for women with cardiac impairment (Class III/IV advised against pregnancy).
    • 🔄 Lifestyle Modifications:
      • Address modifiable risk factors (obesity, smoking, hypertension).


Comments

Popular posts from this blog

ANEMIA IN PREGNANCY : MCQS AND IMPORTANT MCQS By DR MARIA RAFI

IMPORTANT MCQS OF 2024for imm ; fcps ; mcps ; IMM (MUST DO BEFORE EXAM DAY )

IMPORTANT MCQS FILE 3 (70 mcqs) : IMM ; MCPS ; FCPS